Takara Bio USA Launches New Spatial Tech for Archival Samples
New capabilities mark continued momentum as company advances discovery research applications and accelerates the global growth of its spatial biology business Takara Bio USA, Inc....
Category : Healthcare and Pharmaceutical
bioAffinity Technologies Announces $1.8M Nasdaq Direct Financing
bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it...
Vision Restoration for Blinding Eye Conditions
Explore groundbreaking therapies restoring vision lost to blinding eye conditions through gene therapy, retinal implants, and advanced neuroscience. Blindness has long been considered incurable, and...
IMA Medical Group Joins Millennium Physician Group
Millennium Physician Group, one of the largest physician-led healthcare groups in Florida, and IMA Medical Group, one of the largest Central Florida-based provider groups, announced...
CVS Health opens new Workforce Innovation and Talent Center in Fort Worth
In collaboration with Fort Worth Housing Solutions, the center offers no-cost training for Fort Worth’s future health care workforce CVS Health® (NYSE: CVS) is expanding access...
AscellaHealth Leaders Take the Stage at SIIA National Conference
AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces today that two of its senior leaders will serve as featured...
Merck Completes Acquisition of Verona Pharma
Acquisition strengthens Merck’s cardio-pulmonary portfolio with addition of Ohtuvayre® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade Merck (NYSE:...
Aptiva Medical Acquires VeraMed Health
Acquisition Expands National Patient Base and Strengthens Aptiva’s Leadership in Continuous Glucose Monitoring (CGM) Distribution Aptiva Medical, a Greenleaf Ventures portfolio company and one of...
Ignota Labs Acquires Kronos’s Clinical Pipeline
Kronos, once valued at $3.5B, Had Two Phase 2 Stage Assets Ignota Labs, the AI drug turnaround company, has announced its acquisition of Kronos’s clinical...
Within3 Names New Managing Director, Global Head of Consulting
Former Oracle leader joins to advance launch intelligence innovation Within3, the leading Launch Intelligence™ platform for life science, today announced the appointment of Ian McKinnon,...
API Innovation Center Report Highlights Industry Talks on Drug Shortages
Roundtable participants highlight need for predictable demand, transparency and collaboration as the foundation of a sustainable U.S. drug supply chain. The API Innovation Center (APIIC), a...
Scinai Awarded IIA Grant to Expand Fill-and-Finish CDMO Capabilities
Grant funds two-thirds of a NIS 1.23 million ($373K) project to strengthen Scinai Bioservices’ small-batch fill and finish capabilities, addressing a critical need among early-stage biotech companies...
Myeloid Therapeutics Rebrands as CREATE Medicines
CREATE Medicines, Inc. (formerly Myeloid Therapeutics, Inc.) today announced an expanded strategy to move beyond myeloid-focused in vivo programming toward multilineage immune programming, including T cells, myeloid cells,...
CAQH Board Elects New Officers: Timothy Kaja Chair, Susan Smith Vice Chair
UnitedHealth Group’s Timothy Kaja and Centene’s Susan Smith were elected CAQH Board Chair and Vice Chair to advance the nation’s most complete healthcare data foundation and power...
Maryland Stem Cell Fund Grants $4.7M to Advance Stem Cell Research
The grants will drive research and development programs in regenerative medicine across Maryland The Maryland Stem Cell Research Commission (the Commission) awarded $4,707,142 in grant funding to...